Cited by 218Thyroid Disorders and TreatmentsClinical Nutrition and GastroenterologyAdrenal Hormones and Disorders

The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index; 58 of the 130 sources its claims cite were checked for support.

An update on non-thyroidal illness syndrome

Open access
Fliers, E., Boelen, A.·2021·Journal of Endocrinological Investigation

Abstract

The non-thyroidal illness syndrome (NTIS) was first reported in the 1970s as a remarkable ensemble of changes in serum TH (TH) concentrations occurring in probably any severe illness. Ever since, NTIS has remained an intriguing phenomenon not only because of the robustness of the decrease in serum triiodothyronine (T3), but also by its clear correlation with morbidity and mortality. In recent years, it has become clear that (parenteral) feeding in patients with critical illness should be taken into account as a major determinant not only of NTIS but also of clinical outcome. Moreover, both experimental animal and clinical studies have shown that tissue TH concentrations during NTIS do not necessarily reflect serum low TH concentrations and may decrease, remain unaltered, or even increase according to the organ and type of illness studied. These differential changes now have a solid basis in molecular studies on organ-specific TH transporters, receptors and deiodinases. Finally, the role of inflammatory pathways in these non-systemic changes has begun to be clarified. A fascinating role for TH metabolism in innate immune cells, including neutrophils and monocytes/macrophages, was reported in recent years, but there is no evidence at this early stage that this may be a determinant of susceptibility to infections. Although endocrinologists have been tempted to correct NTIS by TH supplementation, there is at present insufficient evidence that this is beneficial. Thus, there is a clear need for adequately powered randomized clinical trials (RCT) with clinically relevant endpoints to fill this knowledge gap.

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

NTIS is a complex, organ- and tissue-specific set of changes in thyroid hormone physiology during illness, not simply low serum thyroid hormone concentrations. Current evidence is insufficient to recommend thyroid hormone treatment, and adequately powered randomized clinical trials with clinically relevant endpoints are needed.

Key findings

  • In an LPS-induced acute illness mouse model, serum T3 and T4 fell only after 24 h, while molecular changes occurred almost simultaneously across the hypothalamus, pituitary, thyroid, and liver.
  • IL-6 knockout mice show a smaller decrease in serum T3 during acute illness; in human volunteers, short-term IL-6 infusion decreased serum TSH, but daily injections over 42 days caused only a modest T3 decrease and transient increases in rT3 and free T4.
  • Tissue thyroid hormone concentrations during NTIS do not necessarily mirror serum levels and may decrease, remain unchanged, or increase depending on organ and illness type, with differential changes in TH transporters, deiodinases, and receptors.
  • There is no clinical evidence to support TH treatment of NTIS in critically ill patients; reported studies were not adequately powered, and normalizing serum TH concentrations does not equal normalizing tissue TH concentrations or local TH action.

Methods

  • Narrative review of experimental animal and clinical studies on NTIS, including human observational data, postmortem tissue studies, and randomized trial subanalyses.
  • Main analysis is a qualitative synthesis of organ-specific thyroid hormone transporters, deiodinases, receptors, inflammatory pathways, nutritional status, and clinical implications.
  • No primary data collection or systematic review methodology is reported.

Limitations

  • Stated: there is insufficient evidence that TH supplementation is beneficial in NTIS, no definitive conclusion about efficacy can be made, and most treatment studies were not adequately powered to detect clinically meaningful differences.
  • Stated: no direct evidence supports the hypothesis that reduced circulating active T3 is a beneficial adaptation, and no solid data answer whether neuroendocrine changes in prolonged critical illness are harmful or should be treated.
  • Evident: as a narrative review, it lacks a systematic search strategy or formal quality appraisal, and it synthesizes heterogeneous animal models, patient populations, and illness stages.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1007/s40618-020-01482-4

Cites

97 of 97 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

58 of 130 cited sources checked · 33 supported · 1 flagged · accuracy not yet measured

Show all 92 claims

  • It may state two separate claims as one. 54
  • Probably not a substantial claim. 32
80 of 80
  • The paper relies on this without support.

    Animal models of NTIS are relevant to human NTIS.

    “In mice, muscle TH transporter expression is low during acute inflammation and bacterial sepsis but remains unchanged during chronic inflammation.”
  • The paper relies on this without support.

    The cited studies' findings are reliable and can be used to draw conclusions about NTIS.

    “Multiple mechanisms are known to be simultaneously involved in the pathogenesis of NTIS.”
2 of 2

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • T3 is described as converting to rT3 and to T2

    Minor

    The nutritional subanalysis describes T3 inactivation as conversion to rT3. Elsewhere, the paper states that DIO3 converts T3 to T2 and T4 to rT3.

1 of 1

Citations

Cites

Flagged first, then by citations

Show all 95 references

Cited by

Sorted by citations

Items 101–200 of 214

Metadata

Authors
Fliers, E., & Boelen, A.
Affiliations
  • Amsterdam UMC Location University of Amsterdam (NL)
  • Amsterdam University Medical Centers (NL)
Corresponding author
Fliers, E.
Venue
Journal of Endocrinological Investigation
Published
2020-12-15
Volume
44
Issue
8
Pages
1597-1607
ISSN
  • 0391-4097 (ISSN-L)
  • 1720-8386
OpenAlex
W3112055569
Cited by
218
References
95
Citations by year
2026: 51 · 2025: 40 · 2024: 49 · 2023: 39 · 2022: 27 · 2021: 12
FWCI
2.49
Type
journal article
Language
en
Open access
Locations
  • Journal of Endocrinological Investigation (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (submittedVersion, cc-by)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
Funders
Amsterdam UMC
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Health Sciences › Nursing › Nutrition and Dietetics › Clinical Nutrition and Gastroenterology
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Keywords
low T3 syndrome, critical illness, triiodothyronine, thyroid hormone transporters, thyroid hormone receptor, thyroid hormone deiodinases, inflammatory signaling, innate immunity, neutrophils, monocytes/macrophages, parenteral nutrition, thyroid hormone replacement, morbidity and mortality
MeSH terms
Diagnosis, Differential, Euthyroid Sick Syndromes, Humans, Thyroid Hormones, Disease Management

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-08, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-08 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review